Dietary supplements for polycystic ovary syndrome.
Authors:
Open Access
- 17 October 2022
- journal article
- review article
- Vol. 63 (2 Suppl 3) , E206-E213
Abstract
Polycystic ovary syndrome (PCOS) is one of the most prevalent female endocrine reproductive disorders, affecting between 4 to 18% of the women in their reproductive age. It is generally characterized by several clinical aspects, among which anovulation, inflammation and infertility. Moreover, PCOS has several health implications, including increased metabolic, reproductive, and psychological risks. Previously, metformin and to some extent thiazolidinediones were considered as drug of choice for PCOS management, but they had several side-effects, and controversial results were obtained about their efficiency, especially in non-insulin-resistant non-obese patients. Thus, alternative treatment options are now being studied for PCOS, including different natural molecules and complementary medicines (CM) for the improvement of their health, wellbeing and fertility. Recently, treatment of PCOS patients with different natural molecules, coming from nutritional supplements and herbal medicines, has attained satisfactory results with the absence of any side effects. In this review, four natural molecules, curcumin, vitamin D, inositol and CoQ10 are discussed for their therapeutic ability. These molecules proved to decrease insulin sensitivity and inflammation, to improve the restoration of ovarian function, and they could restore hormonal balance and regulate the menstrual cycle, all of which are the main features and major concerns for women suffering from PCOS.Keywords
This publication has 65 references indexed in Scilit:
- Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular diseaseNeurology, 2013
- Inflammation in Polycystic Ovary Syndrome: Underpinning of insulin resistance and ovarian dysfunctionSteroids, 2012
- Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previousin vitrofertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort studyGynecological Endocrinology, 2011
- Evidence that α-lipoic acid inhibits NF-κB activation independent of its antioxidant functionInflammation Research, 2010
- Role of Vitamin D in Insulin Secretion and Insulin Sensitivity for Glucose HomeostasisInternational Journal of Endocrinology, 2010
- Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndromeEuropean Journal of Endocrinology, 2009
- Melatonin and the ovary: physiological and pathophysiological implicationsFertility and Sterility, 2009
- Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trialHuman Reproduction, 2007
- The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2007
- Inhibition of Sex Hormone-Binding Globulin Production in the Human Hepatoma (Hep G2) Cell Line by Insulin and Prolactin*The Journal of Clinical Endocrinology & Metabolism, 1988